Editorial comment on: Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer.
Andrea
A
Cestari
Giorgio
G
Guazzoni
D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000628:therapy*; D011471:Prostatic Neoplasms / Q000532:radiotherapy / Q000628:therapy*; D016879:Salvage Therapy / Q000379:methods*; D013997:Time Factors; D017211:Treatment Failure; D016896:Treatment Outcome; D014464:Ultrasonic Therapy